| Discipline name | D-Index | World Ranking | Current World Ranking | National Ranking | Current National Ranking | Publications | Citations |
|---|---|---|---|---|---|---|---|
| Molecular Biology | 49 | 2588 | 2339 | 1268 | 1136 | 128 | 30610 |
The chart shows the history of publications by Ed Reznik between 2010 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Ed Reznik published across 17 years, from 2010 to 2026, averaging 15.8 papers a year. Output peaked at 81 publications in 2023. 19 of the 268 publications appeared in the last two years.
268 publications in total across all disciplines
| Year | Publications |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 14 |
| 2017 | 14 |
| 2018 | 28 |
| 2019 | 14 |
| 2020 | 20 |
| 2021 | 19 |
| 2022 | 23 |
| 2023 | 81 |
| 2024 | 22 |
| 2025 | 18 |
| 2026 | 1 |
| Total | 268 |
The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Ed Reznik sits on this spectrum.
This scientist: 128 publications — 26th percentile
26% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 564 publications or more.
| Publications | Scientists | This scientist |
|---|---|---|
| 47–56 | 7 | |
| 57–66 | 17 | |
| 67–76 | 65 | |
| 77–86 | 90 | |
| 87–96 | 125 | |
| 97–106 | 131 | |
| 107–116 | 162 | |
| 117–126 | 177 | |
| 127–136 | 158 | 128 |
| 137–146 | 158 | |
| 147–156 | 146 | |
| 157–166 | 159 | |
| 167–176 | 131 | |
| 177–186 | 110 | |
| 187–196 | 112 | |
| 197–206 | 100 | |
| 207–216 | 89 | |
| 217–226 | 98 | |
| 227–236 | 74 | |
| 237–246 | 72 | |
| 247–256 | 63 | |
| 257–266 | 53 | |
| 267–276 | 54 | |
| 277–286 | 49 | |
| 287–296 | 52 | |
| 297–306 | 43 | |
| 307–316 | 46 | |
| 317–326 | 41 | |
| 327–336 | 42 | |
| 337–346 | 31 | |
| 347–356 | 28 | |
| 357–366 | 29 | |
| 367–376 | 26 | |
| 377–386 | 24 | |
| 387–396 | 24 | |
| 397–406 | 14 | |
| 407–416 | 13 | |
| 417–426 | 20 | |
| 427–436 | 12 | |
| 437–446 | 20 | |
| 447–456 | 11 | |
| 457–466 | 10 | |
| 467–476 | 14 | |
| 477–486 | 14 | |
| 487–496 | 10 | |
| 497–506 | 13 | |
| 507–516 | 13 | |
| 517–526 | 2 | |
| 527–536 | 4 | |
| 537–546 | 6 | |
| 547–556 | 8 | |
| 557–563 | 6 | |
| 564+ | 100 |
The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Ed Reznik sits on this spectrum.
This scientist: 49 D-Index — 16th percentile
16% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 145 D-Index or more.
| D-Index | Scientists | This scientist |
|---|---|---|
| 40–41 | 36 | |
| 42–43 | 101 | |
| 44–45 | 115 | |
| 46–47 | 121 | |
| 48–49 | 118 | 49 |
| 50–51 | 130 | |
| 52–53 | 106 | |
| 54–55 | 116 | |
| 56–57 | 113 | |
| 58–59 | 129 | |
| 60–61 | 120 | |
| 62–63 | 105 | |
| 64–65 | 131 | |
| 66–67 | 95 | |
| 68–69 | 97 | |
| 70–71 | 106 | |
| 72–73 | 83 | |
| 74–75 | 89 | |
| 76–77 | 77 | |
| 78–79 | 70 | |
| 80–81 | 73 | |
| 82–83 | 60 | |
| 84–85 | 48 | |
| 86–87 | 45 | |
| 88–89 | 50 | |
| 90–91 | 31 | |
| 92–93 | 51 | |
| 94–95 | 43 | |
| 96–97 | 38 | |
| 98–99 | 39 | |
| 100–101 | 41 | |
| 102–103 | 29 | |
| 104–105 | 33 | |
| 106–107 | 35 | |
| 108–109 | 20 | |
| 110–111 | 38 | |
| 112–113 | 19 | |
| 114–115 | 28 | |
| 116–117 | 13 | |
| 118–119 | 23 | |
| 120–121 | 16 | |
| 122–123 | 15 | |
| 124–125 | 11 | |
| 126–127 | 21 | |
| 128–129 | 7 | |
| 130–131 | 13 | |
| 132–133 | 14 | |
| 134–135 | 17 | |
| 136–137 | 9 | |
| 138–139 | 8 | |
| 140–141 | 16 | |
| 142–143 | 7 | |
| 144 | 7 | |
| 145+ | 100 |
Ed Reznik is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research spans multiple fields, primarily focusing on biochemistry, genetics, and molecular biology, as well as medicine. The scientist has contributed extensively to various subfields, including molecular biology, pulmonary and respiratory medicine, cancer research, oncology, and surgery.
Reznik's work concentrates on several key topics within the biomedical sciences. These include renal cell carcinoma treatment, cancer genomics and diagnostics, renal and related cancers, ferroptosis and cancer prognosis, bioinformatics and genomic networks, cancer immunotherapy and biomarkers, and computational drug discovery methods.
The scientist has published numerous papers, with notable recent works such as:
Frequent publication venues for Reznik include:
Collaborations form a significant component of the scientist's work. Frequent co-authors include A. Ari Hakimi, Robert J. Motzer, Jonathan Coleman, Ritesh R. Kotecha, and Paul Russo. These collaborations reflect a diverse network within cancer research and urology.
Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf
Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf
Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta
W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao
André Kahles;Kjong-Van Lehmann;Nora C Toussaint;Matthias Hüser
Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter
Joshua Armenia;Stephanie A. M. Wankowicz;Stephanie A. M. Wankowicz;David Liu;David Liu;Jianjiong Gao
Christopher J Ricketts;Aguirre A De Cubas;Huihui Fan;Christof C Smith
Samra Turajlic;Samra Turajlic;Hang Xu;Kevin Litchfield;Andrew Rowan
A. Ari Hakimi;Ed Reznik;Chung Han Lee;Chad J. Creighton
Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta
Ed Reznik;Martin Lee Miller;Yasin Şenbabaoğlu;Nadeem Riaz
Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi
Joshua D. Campbell;Joshua D. Campbell;Joshua D. Campbell;Christina Yau;Christina Yau;Reanne Bowlby;Yuexin Liu
Fengju Chen;Yiqun Zhang;Yasin Şenbabaoğlu;Giovanni Ciriello
Elad Noor;Arren Bar-Even;Avi I. Flamholz;Ed Reznik
Bastien Nguyen;Christopher Fong;Anisha Luthra;Shaleigh A. Smith
Christopher J Ricketts;Aguirre A De Cubas;Huihui Fan;Christof C Smith
If you think any of the details on this page are incorrect, let us know.
Studying Molecular Biology can open the door to a range of healthcare careers, including advanced roles in nursing and research. If you’re considering a path that bridges biology with patient care, exploring online nursing degrees may be a practical next step.
For those interested in transitioning careers, there are accelerated programs tailored to various educational backgrounds. For example, the direct entry msn programs for non nurses online are designed for individuals without nursing experience but who want to quickly enter the field. Others who are already registered nurses may prefer the 6-month rn to bsn program to boost their credentials in a short span.
Those aiming for advanced roles, like nurse practitioner, should explore pathways outlining how to become nurse practitioner. Additionally, bridge programs, such as adn to np programs online, provide flexible options for registered nurses with an associate degree to accelerate their journey toward leadership roles.
With these online options, a foundation in Molecular Biology can be leveraged into diverse and fulfilling healthcare career pathways.
Korea Institute of Science and Technology
Spanish National Research Council
University of Tübingen
University of Wisconsin–Madison
California Institute of Technology
University of California, Los Angeles
Soochow University
Pacific Northwest National Laboratory
Utrecht University
Centre national de la recherche scientifique, CNRS
University of Arizona
Graz University of Technology
Philipp University of Marburg
University of Queensland
McGill University
Versailles Saint-Quentin-en-Yvelines University
